THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: 10-Q filed 2017-04-17

Name: THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: 10-Q filed 2017-04-17
Creator: THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

What THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. reported in its quarterly report filed 2017-04-17 (fiscal Q3 2016): 25 published measures, 66 facts as tagged in accession 0001078782-17-000491.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-04-17
Fiscal period: fiscal Q3 2016
Accession: 0001078782-17-000491 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-09-30	125,715	USD
At 2015-12-31	259,964	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2016-09-30	-486,075	USD
At 2015-12-31	-229,028	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2016-09-30	45,233	USD
At 2016-01-01	2,183	USD
At 2015-09-30	8,494	USD
At 2015-01-01	2,894	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-182,748	USD	92
2016-01-02 to 2016-09-30	-691,200	USD	273
2015-07-01 to 2015-09-30	-179,796	USD	92
2015-01-02 to 2015-09-30	-377,618	USD	272

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2016-01-02 to 2016-09-30	-287,806	USD	273
2015-01-02 to 2015-09-30	-97,788	USD	272

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2016-01-02 to 2016-09-30	330,856	USD	273
2015-01-02 to 2015-09-30	103,388	USD	272

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2016-01-02 to 2016-09-30	0	USD	273
2015-01-02 to 2015-09-30	0	USD	272

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2016-09-30	-3,901,937	USD
At 2015-12-31	-3,210,737	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-179,382	USD	92
2016-01-02 to 2016-09-30	-681,583	USD	273
2015-07-01 to 2015-09-30	-178,495	USD	92
2015-01-02 to 2015-09-30	-364,756	USD	272

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-09-30	96,871	USD
At 2015-12-31	247,488	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-3,366	USD	92
2016-01-02 to 2016-09-30	-9,617	USD	273
2015-07-01 to 2015-09-30	-1,301	USD	92
2015-01-02 to 2015-09-30	-4,140	USD	272

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2016-09-30	611,790	USD
At 2015-12-31	488,992	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2016-09-30	321,691	USD
At 2015-12-31	277,342	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	180,309	USD	92
2016-01-02 to 2016-09-30	683,419	USD	273
2015-07-01 to 2015-09-30	178,654	USD	92
2015-01-02 to 2015-09-30	365,237	USD	272

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2016-09-30	38,351	USD
At 2015-12-31	29,675	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	927	USD	92
2016-01-02 to 2016-09-30	1,836	USD	273
2015-07-01 to 2015-09-30	159	USD	92
2015-01-02 to 2015-09-30	481	USD	272

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	0	USD	92
2016-01-02 to 2016-09-30	5,990	USD	273
2015-07-01 to 2015-09-30	0	USD	92
2015-01-02 to 2015-09-30	0	USD	272

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2016-09-30	695,251,000	shares
At 2015-12-31	541,000,000	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2016-09-30	2,720,611	USD
At 2015-12-31	2,440,709	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2016-09-30	91,430	USD
At 2015-12-31	17,986	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	26,065	USD	92
2016-01-02 to 2016-09-30	101,786	USD	273
2015-07-01 to 2015-09-30	25,727	USD	92
2015-01-02 to 2015-09-30	56,991	USD	272

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2016-01-02 to 2016-09-30	332,000	USD	273
2015-01-02 to 2015-09-30	105,000	USD	272

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-01-02 to 2016-09-30	2,184	USD	273
2015-01-02 to 2015-09-30	0	USD	272

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-01-02 to 2016-09-30	-8,676	USD	273
2015-01-02 to 2015-09-30	-28,572	USD	272

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2016-01-02 to 2016-09-30	44,349	USD	273
2015-01-02 to 2015-09-30	-1,065	USD	272

Inspect the source

Entity: THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. / CIK 0001419051
Captured: 2026-09-21T17:19:45.690Z
SEC response SHA-256: ad44380627053f8e0101ecf19c259e20a0a85d4c20ee53d5400d9dcf00541fc2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001419051.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))